← Back to headlines
Eli Lilly Shares Climb on Stronger Revenue Outlook Driven by Obesity Drugs
Eli Lilly's stock saw a significant increase after the company released a stronger revenue outlook, primarily attributed to the strong performance and future potential of its obesity drug portfolio.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
